Why broker JP Morgan just upgraded the Pilbara Minerals share price

Is a broker's call the reason for the lithium miner's strong rise?

| More on:
a man leans back in his chair with his arms supporting his head as he smiles a satisfied smile while sitting at his desk with his laptop computer open in front of him.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • Pilbara Minerals is a strong performer today, up more than 6%
  • The lithium miner has received another positive broker upgrade, this time from JP Morgan
  • It’s also currently benefiting from strong lithium prices

The Pilbara Minerals Ltd (ASX: PLS) share price has shot higher today. It's currently up by more than 6%.

This means it's now around 36% higher over the past month and has gone up 90% since the middle of June 2022.

While some of the increase in recent weeks may simply be a reversal of the declines seen earlier in the year, the company is now trading higher than it was before.

So, what could be causing the latest gains?

Brokers are still positive on the Pilbara Minerals share price

According to reporting by The Australian, the broker JP Morgan has decided that the ASX lithium share still has further upside.

The analyst Lydon Fagan from JP Morgan has upgraded the business to an outperform rating and has lifted the price target by another 17% to $4.10. A price target is where the broker thinks the share price will be trading in 12 months from the date of the rating.

A key reason for the increase in the price target is that JP Morgan has increased its long-term estimates for lithium prices because of a "steeper cost curve to incentivise low-grade Chinese supply to fill the supply-demand gap."

The broker thinks that the lithium market could be undersupplied until 2025. That means the relationship between supply and demand could favour Pilbara Minerals for a while yet.

JP Morgan has increased its long-term forecast for lithium carbonate and spodumene prices — they were increased by 20% and 25% respectively.

Electric vehicle demand is likely to grow in the longer term, but supply chain issues and a recession could hurt growth.

The price target of $4.10 implies a possible rise of around 5% over the next year from the current level.

Another positive rating

JP Morgan isn't the only broker positive on further gains for Pilbara Minerals.

Macquarie also rates the ASX lithium share as outperform. But it has a much stronger outlook for the Pilbara Minerals share price. Macquarie's price target is $5.60. This implies a possible rise of more than 40%.

The reason for Macquarie's optimism is that Pilbara Minerals is predicting that its production could increase by more than half in FY23. When combined with the high lithium price, this combination is expected to lead to a significant rise in net profit after tax (NPAT) and cash flow.

Pilbara Minerals share price snapshot

Over the last six months, the lithium miner's share price has risen by around 40%.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

three men stand on a winner's podium with medals around their necks with their hands raised in triumph.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy end to the trading week this Friday.

Read more »

A business person directs a pointed finger upwards on a rising arrow on a bar graph.
Share Gainers

3 ASX 200 stocks storming higher in this week's sinking market

Investors have sent these three ASX 200 stocks soaring this week. But why?

Read more »

Two smiling work colleagues discuss an investment at their office.
Share Gainers

Why 4DMedical, Develop Global, EOS, and Maas shares are racing higher today

These shares are ending the week on a high. But why?

Read more »

Six smiling health workers pose for a selfie.
Healthcare Shares

Up 657% in a year, 4DMedcial shares rocketing another 20% today on big US news

ASX investors can’t get enough of 4DMedical shares today. Let’s see why.

Read more »

A neon sign says 'Top Ten'.
Share Gainers

Here are the top 10 ASX 200 shares today

The ASX 200 broke its losing streak to inch higher today.

Read more »

Wife and husband with a laptop on a sofa over the moon at good news.
Consumer Staples & Discretionary Shares

Bapcor shares soar 12% on the appointment of a new CEO

The market’s strong reaction reflects a clear message: investors are ready for a reset.

Read more »

A young woman drinking coffee in a cafe smiles as she checks her phone.
Share Gainers

Why Bapcor, IDP Education, Netwealth, and Ora Banda shares are pushing higher today

These shares are catching the eye with solid gains on Thursday. But why are they rising?

Read more »

Medical workers examine an xray or scan in a hospital laboratory.
Healthcare Shares

This ASX stock is going parabolic, and I think it's still a buy

4DMedical shares are up nearly 500% in 2025, but improving revenue visibility suggests the growth story may not be over.

Read more »